Evidence map›Paper›PMID 29995562›Full record

ArticleRNA biology2018

Knockdown of lncRNA BDNF-AS suppresses neuronal cell apoptosis via downregulating miR-130b-5p target gene PRDM5 in acute spinal cord injury.

Huafeng Zhang, Dongzhe Li, Yi Zhang, Jianqiang Li, Shengli Ma, Jianwei Zhang, Yuanyuan Xiong, Wengang Wang, Ning Li, Lei Xia

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Biosensors, Recent Advances in Determination of BDNF and NfL.Cellular and molecular neurobiology · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Huafeng Zhanga Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Dongzhe Lia Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Yi Zhanga Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Jianqiang Lia Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Shengli Maa Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Jianwei Zhangb Department of Urology , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Yuanyuan Xiongc Department of Hematology , The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital , Zhengzhou , Henan Province , China.
Wengang Wanga Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Ning Lia Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
Lei Xiaa Department of Orthopedics , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , Henan Province , China.
First Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe present study was designed to investigate the molecular mechanism and biological roles of lncRNA brain-derived neurotrophic factor antisense (lncRNA BDNF-AS) in acute spinal cord injury (ASCI).

methodsThe rat model of ASCI and hypoxic cellular model were established to detect the expression of BDNF-AS, miR-130b-5p, PR (PRDI-BF1 and RIZ) domain protein 5 (PRDM5) and cleaved caspase 3 (c-caspase 3) using qRT-PCR and western blot. Basso, Beattie and Bresnahan (BBB) score was carried out to assess neurological function. Flow cytometry was used to determine the apoptosis of neuronal cells. The association among BDNF-AS, miR-130b-5p and PRDM5 were disclosed by RNA immunoprecipitation (RIP) assay, RNA pull-down assay and dual-luciferase reporter assay.

resultsBDNF-AS, PRDM5 and c-caspase 3 expression were significantly upregulated, while miR-130b-5p was suppressed in the ASCI group and neuronal cells following hypoxia treatment. BDNF-AS knockdown inhibited neuronal cell apoptosis. Further studies indicated that BDNF-AS functioned as a competing endogenous RNA (ceRNA) by sponging miR-130b-5p in neuronal cells. Further investigations demonstrated that PRDM5 was a target of miR-130b-5p and BDNF-AS knockdown exerted anti-apoptotic effects via miR-130b-5p/PRDM5 axis.

conclusionThe lncRNA BDNF-AS/miR-130b-5p/PRDM5 axis might be a promising therapeutic target for ASCI.

Indexed as

ApoptosisAcute DiseaseAnimalsBrain-Derived Neurotrophic FactorCell ProliferationDisease Models, AnimalGene Expression Regulation, NeoplasticMaleMicroRNAsNeuronsPositive Regulatory Domain I-Binding Factor 1RatsRats, Sprague-DawleyRNA, Long NoncodingSpinal Cord InjuriesTranscription FactorsBdnf protein, ratBrain-Derived Neurotrophic FactorMicroRNAsMIRN130 microRNA, ratPositive Regulatory Domain I-Binding Factor 1PRDM5 protein, ratRNA, Long NoncodingTranscription FactorsAcute spinal cord injuryapoptosislncRNA BDNF-ASmiR-130b-5pPRDM5

Identifiers

PMID29995562
PMCPMC6161672
OpenAlexW2836017156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.